Peektastic.com

Eli Lilly's experimental diabetes drug cuts weight by 17% in study

Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 trial, topping all rivals. [...]

Discover Copy

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Facebook scammers want you to think Elon Musk can cure diabetes

Elon Musk discovered a simple 30-second “fridge trick” that can reverse diabetes, but the discovery has spooked pharmaceutical companies so much they put a $78 million bounty on his head, forcing [...]

More Copy

Match Score: 122.34

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.Read more... [...]

More Copy

Match Score: 104.96

Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine

US pharmaceutical giant Eli Lilly is betting big on AI-driven drug development, signing a $2.75 billion deal with Hong Kong-listed Insilico Medicine.<br /> The article Eli Lilly signs $2.75 bill [...]

More Copy

Match Score: 87.74

Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’s

Just about a year after launching a direct-to-consumer online platform to sell treatments for diabetes and obesity, Eli Lilly (LLY) is now expanding the program to offer resources for Alzheimer’s d [...]

More Copy

Match Score: 78.56

Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk

The diabetes drug, already the top-prescribed branded type 2 diabetes medicine in the U.S., showed an 8% lower rate of major heart events than Lilly's older drug Trulicity [...]

More Copy

Match Score: 77.85

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally. Three U.S. sen [...]

More Copy

Match Score: 74.93

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

More Copy

Match Score: 72.26

Eli Lilly is coming after makers of copycat versions of Zepbound

Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound.Read more... [...]

More Copy

Match Score: 64.97

The best smart scales for 2025

The New Year is here and there’s no better time to kickstart those health and fitness goals. Whether you’re looking to shed a few holiday pounds, track your muscle gains or simply stay on top of a [...]

More Copy

Match Score: 64.66